NCT06571669ClinicalTrials.gov

BOOM-IBD2 Pivotal Clinical Trial

BOOM-IBD2 Clinical Trial to Evaluate the Effectiveness of Sacral Neuromodulation for the Treatment of IBD.

قيد التجنيديقبل مشاركين الآن، وفقاً لسجل السجل.

التواصل مع هذه الدراسة

باختصار

Ulcerative colitis is a long-lasting condition that causes swelling and sores in the large intestine. This study tests whether a small device placed under the skin can help reduce bowel urgency in people with ulcerative colitis. The investigational device sends…

تدخّليةمطلوب 137 مشاركاً19 موقعاًدولة واحدة

الفئات

أمراض الجهاز الهضمي والكبد96%الأمراض الجلدية4%

مسجَّلة في سجل واحد

ClinicalTrials.govNCT06571669فتح هذا السجل في ClinicalTrials.govتمت المزامنة الشهر الماضي

يمكن أن تُسجَّل دراسة واحدة في عدة سجلات. نعرضها مرة واحدة ونربط بكل سجل نحتفظ به.

تُعرض معلومات التجربة كما نشرها السجل، بلغتها الأصلية.

هل أنت مهتم بهذه الدراسة؟

تسجيل الدخول أو أنشئ حسابًا لتسجيل اهتمامك ومتابعة هذه الدراسة.

How this study is set up

The points below are drawn from the public registry record for this study. Each one cites the field or sentence it came from. A dash (—) means the record does not state something — not that it is missing or wrong. Many well-run studies, especially small ones, leave some of these blank.

Present: Registered before enrolment beganFirst posted 2024-08-26; recorded start 2025-01-31
Present: Has a defined primary outcomeA primary outcome measure is listed in the record
Present: The primary outcome states a time frameThe primary outcome measure records a time frame
Not stated: Participants are not randomly assignedAllocation is recorded as non-randomised
Not stated: A comparison group is not stated in the registry recordThe record describes a single study arm
Not stated: Open label (no blinding)Masking is recorded as none (open label)
Not stated: An ethics committee is not stated in the registry recordThis registry's ingested record has no ethics-committee field
Not stated: Regulatory oversight (such as an IND or IDE) is not stated in the registry recordThis registry's ingested record has no regulatory-authorisation field
Not stated: A data monitoring committee is not stated in the registry recordThis registry's ingested record has no data-monitoring-committee fieldA data monitoring committee is not required for many smaller studies, and its absence here is not unusual.
Present: No cost to participants is mentioned in the recordChecked the summary, description and eligibility text; no cost-to-participant phrase found
Not stated: No other studies from this sponsor are in this databaseCounted from the lead sponsor named in the record (Boomerang Medical)
Not stated: No posted results from this sponsor are in this database yetBased on the sponsor’s studies in this database

The record lists 2 conditions.
Lead sponsor type recorded as: industry.

These are facts from the public registry record, not a judgement about the study. Discuss any trial with your own doctor before taking part.

What these facts mean, and what to ask · ruleset v1

Trial stature

Three independent measures of this study, described from its registry record — not a recommendation about it. A rigorous study by investigators nobody has heard of is better evidence than a weak study led by a famous one. How these are scored.

Methodological rigourEXPLORATORY

An exploratory-stage design for a study of this type, judged from its ClinicalTrials.gov record.

How this score is built

Randomised allocation0/20
Allocation not stated in the record
Blinding0/20
Open-label
Control arm0/15
No comparator arm stated in the record
Primary-outcome specificity10/10
Named primary outcome with a defined time frame
Endpoint type3/10
Surrogate or intermediate endpoint (conservative default)
Multi-centre8/8
Multi-centre: 19 sites
Data monitoring committee0/7
No data monitoring committee stated
Prospective registration5/5
Registered before the study start date
Protocol / SAP posted0/5
No protocol or SAP posted to the registry

ScaleSMALL

A small study: 137 participants (target), run at 19 sites.

How this score is built

Enrolment20/40
137 participants (target)
Site count15/25
19 sites
Country count0/15
Single country
Planned duration8/10
Planned over about 34 months
Sponsor scale0/10
Boomerang Medical has led 1 trials in our corpus

Investigator standingUNKNOWN

We have no verifiable track record for the investigator named on this trial. That is common for early-career investigators and for records held outside ClinicalTrials.gov — it is not a negative signal.

How this score is built

Investigator standing0/100
No investigator recorded in the registry for this trial

These describe the registry record only, and today we hold ClinicalTrials.gov data. Absent fields lower a score, and absence often reflects registration practice rather than study quality. A high-stature trial is not necessarily safer or a better choice for you — enrolling in a large definitive trial can mean a higher chance of receiving placebo, while a small early-phase study may be the only route to a new therapy.

ملخص

The main goal is to find out if bowel urgency gets better after 12 weeks, using a standard rating scale for bowel urgency. Adults ages 18 to 85 with ulcerative colitis may be able to join. Everyone in the study gets the device. There is no placebo group. Study visits continue for 12 months.

الحالات

Ulcerative Colitis
Inflammatory Bowel Diseases

الأهلية

الأهلية
الجنس	الجميع
الأعمار	18 Years – 85 Years
المتطوعون الأصحّاء	لا

الأهلية كما كُتبت في السجل

Inclusion Criteria: * Male or female * 18 to 85 years of age * Diagnosed with ulcerative colitis * Ability and willingness to consent to participate by signing the informed consent form * Ability to comply with the protocol and willingness to comply with all follow up requirements Exclusion Criteria: * Any significant medical condition that is likely to interfere with study procedures, device operation, or likely to confound the results of the study * Any psychiatric or personality disorder at the discretion of the study investigator * Any active bacterial infection with a risk of bacteremia or sepsis (e.g. presence of abscess) * Active clostridium difficile infection of the colon * Active cytomegalovirus (CMV) infection of the colon * Evidence of colonic perforation * Fulminant colitis requiring emergency surgery * Microscopic, ischemic or infectious colitis * Unresected neoplasia of the colon * Colonic stricture unable to pass a colonoscope * Current evidence of cancer in the gastrointestinal tract * Current participation in another clinical trial * Previous history of surgery for ulcerative colitis, or probably to require such intervention * Previously implanted with a neurostimulation device or participated in a neurostimulation trial * Inability to operate the patient programmer

الأهلية في عبارات بسيطة

لم تُقسَّم معايير هذا السجل إلى عبارات منفصلة بعد. نص السجل أعلاه كامل وهو النسخة المُعتمَدة.

تصميم الدراسة

تصميم الدراسة
نوع الدراسة	تدخّلية
المرحلة	غير منطبق
التخصيص	غير منطبق
نموذج التدخّل	SINGLE_GROUP
الغرض الأساسي	TREATMENT
التعمية	NONE (0)
التجنيد	مطلوب 137 مشاركاً

الجهة الراعية والمتعاونون

Boomerang Medical الجهة الراعية

الأذرع والتدخلات

Treatment ArmEXPERIMENTAL
Patients implanted with neuromodulation

التدخلات

جهاز Neuromodulation
Neuromodulation

مقاييس النتائج

مقياس النتيجة الأولي
Bowel Urgency
Bowel urgency at 12 weeks using the urgency numeric rating scale (URNS). The Urgency NRS is a patient-reported outcome (PRO) that quantifies the severity of bowel urgency on a scale from 0 to 10, where 0 equals no bowel urgency and 10 equals worst possible urgency.
الإطار الزمني 12 weeks

التواريخ

التواريخ
تاريخ البدء	31 يناير 2025 (فعلي)
الإتمام الأولي	28 فبراير 2027 (تقديري)
الإتمام	30 نوفمبر 2027 (تقديري)
أول نشر	26 أغسطس 2024 (فعلي)
آخر تحديث	6 أغسطس 2026
النتائج منشورة	غير مذكور في سجل السجل
آخر تأكيد للحالة	أغسطس 2026

فعلي يعني أن الحدث وقع. تقديري يعني أن الجهة الراعية تتوقعه. للكلمتين معنيان مختلفان.

المواقع

16 موقعاً قيد التجنيد

United States

United States
المنشأة	المدينة	الولاية أو المنطقة	الحالة
Amarillo Premier Research (Objective Health)	Amarillo	Texas	قيد التجنيد
UNC Chapel Hill	Chapel Hill	North Carolina	قيد التجنيد
Columbia Digestive Health Research (Objective Health)	Columbia	South Carolina	قيد التجنيد
Gastroenterology Medical Clinic (Objective Health)	Folsom	California	قيد التجنيد
GI Alliance	Jackson	Mississippi	قيد التجنيد
Las Vegas Medical Research LLC, DBA Vector Clinical Trials	Las Vegas	Nevada	قيد التجنيد
Center for Colorectal Innovation	Los Angeles	California	قيد التجنيد
Northwell Health North Shore University Hospital	Manhasset	New York	قيد التجنيد
Great Lakes Gastro	Mentor	Ohio	مسحوب
Columbia University Irving Medical Center/New York Presbyterian Hospital	New York	New York	قيد التجنيد
Hoag Hospital	Newport Beach	California	قيد التجنيد
PAMF (Palo Alto Medical Foundation)	Palo Alto	California	قيد التجنيد
Pennsylvania Hospital	Philadelphia	Pennsylvania	لم يبدأ التجنيد بعد
Sanford Health	Sioux Falls	South Dakota	قيد التجنيد
Gateway GI Research (Objective Health)	St Louis	Missouri	قيد التجنيد
Digestive Research of Central Texas (Objective Health)	Waco	Texas	قيد التجنيد
Kansas Gastro	Wichita	Kansas	قيد التجنيد
Digestive Health Research of North Texas (Objective Health)	Wichita Falls	Texas	نشط، دون تجنيد
MN Urology	Woodbury	Minnesota	قيد التجنيد

مستندات الدراسة

لا تُرتبط أي مستندات في سجل السجل هذا.

التغيّرات عبر الزمن

لم تُسجَّل أي تغييرات منذ أن أدرجنا هذا السجل لأول مرة.

يُسجَّل تغيير في كل مرة تحدّث فيها الجهة الراعية سجل السجل. تظهر هنا الحالة والتواريخ والتجنيد والمواقع كلما تغيّرت.

السجل: ClinicalTrials.gov · NCT########

https://xmedica.io/trials/ctgov/NCT06571669